Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michlmayr

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Immunology|July 1, 1975
Increased proliferation of T lymphocytes in the blood of patients with Hodgkin's diseaseC Huber, G Michlmayr, M Falkensamer, et al.
Blood|November 1, 1978
Expression and specificity of FcIgG receptor sites on neoplastic lymphocytesC Huber, H D Flad, K Nilsson, et al.
Onkologie|February 1, 1989
Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German resultsW Linkesch, G Michlmayr, H Gerhartz, et al.
British Journal of Haematology|September 1, 1978
A comparative study of the buoyant density distribution of normal and malignant lymphocytesC Huber, K Zier, G Michlmayr, et al.
Wiener Klinische Wochenschrift|August 26, 1983
[Results of cytostatic polychemotherapy in non-Hodgkin lymphomas]H Kratzer, W Hehenwarter, H Denz, et al.
Annals of Hematology|February 1, 1995
Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemiaE Koller, H Karlic, O Krieger, et al.
Blut|March 1, 1985
Surface glycoproteins (S-GP) on normal and malignant human leukocytesE Leiter, R Pfister, D Lutz, et al.
Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Klinische Wochenschrift|July 1, 1977
[The differentiation of human peripheral blood lymphocytes by immunological methods. III. Results in acute lymphoblastic leukemia (author's transl)]C Pathouli, G Michlmayr, C Huber, et al.
Leukemia Research|October 10, 1998
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemiaW Hilbe, U Apfelbeck, M Fridrik, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Immunology|July 1, 1975
Increased proliferation of T lymphocytes in the blood of patients with Hodgkin's diseaseC Huber, G Michlmayr, M Falkensamer, et al.
Blood|November 1, 1978
Expression and specificity of FcIgG receptor sites on neoplastic lymphocytesC Huber, H D Flad, K Nilsson, et al.
Onkologie|February 1, 1989
Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German resultsW Linkesch, G Michlmayr, H Gerhartz, et al.
British Journal of Haematology|September 1, 1978
A comparative study of the buoyant density distribution of normal and malignant lymphocytesC Huber, K Zier, G Michlmayr, et al.
Wiener Klinische Wochenschrift|August 26, 1983
[Results of cytostatic polychemotherapy in non-Hodgkin lymphomas]H Kratzer, W Hehenwarter, H Denz, et al.
Annals of Hematology|February 1, 1995
Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemiaE Koller, H Karlic, O Krieger, et al.
Blut|March 1, 1985
Surface glycoproteins (S-GP) on normal and malignant human leukocytesE Leiter, R Pfister, D Lutz, et al.
Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Klinische Wochenschrift|July 1, 1977
[The differentiation of human peripheral blood lymphocytes by immunological methods. III. Results in acute lymphoblastic leukemia (author's transl)]C Pathouli, G Michlmayr, C Huber, et al.
Leukemia Research|October 10, 1998
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemiaW Hilbe, U Apfelbeck, M Fridrik, et al.
Pageof 8